Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C

por Wu, Ye-Jiao, Xu, Ming-Yi, Lu, Lun-Gen
Publicado 2014

18α-Glycyrrhetinic Acid Down-Regulates Expression of Type I and III Collagen via TGF-Β1/Smad Signaling Pathway in Human and Rat Hepatic Stellate Cells

por Zong, Lei, Qu, Ying, Xu, Ming-yi, Dong, Yu-wei, Lu, Lun-gen
Publicado 2012

18α-Glycyrrhizin induces apoptosis and suppresses activation of rat hepatic stellate cells

por Qu, Ying, Chen, Wei-Hua, Zong, Lei, Xu, Ming-Yi, Lu, Lun-Gen
Publicado 2012

Hepatocyte-derived exosomal miR-27a activateshepatic stellate cells through the inhibitionof PINK1-mediated mitophagy in MAFLD

por Luo, Xin, Xu, Zi-Xin, Wu, Jun-Cheng, Luo, Sheng-Zheng, Xu, Ming-Yi
Publicado 2021

Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells

por Feng, Yi, Ying, Hai-yan, Qu, Ying, Cai, Xiao-bo, Xu, Ming-yi, Lu, Lun-gen
Publicado 2016

MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2

por Wu, Jun-Cheng, Chen, Rong, Luo, Xin, Li, Zheng-Hong, Luo, Sheng-Zheng, Xu, Ming-Yi
Publicado 2019

Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α

por Liu, Ting, Luo, Xin, Li, Zheng-Hong, Wu, Jun-Cheng, Luo, Sheng-Zheng, Xu, Ming-Yi
Publicado 2019

Evaluating the Therapeutic Efficacy of Si-Wu-Tang Decoction and Concentrated Extract in Follicular Maldevelopment-Related Menstrual Disorders Through Pharmacokinetic/Pharmacodynami...

por Lee, Chia-Jung, Kapelemera, Alinafe Magret, Tsai, Yi-Zhe, Lee, Ching-Tzu, Xu, Ming-Yi, Wang, Ching-Chiung
Publicado 2020

Linc-SCRG1 accelerates progression of hepatocellular carcinoma as a ceRNA of miR26a to derepress SKP2

por Hu, Jun-Jie, Zhou, Cui, Luo, Xin, Luo, Sheng-Zheng, Li, Zheng-Hong, Xu, Zi-Xin, Xu, Ming-Yi
Publicado 2021

Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease

por Luo, Xin, Luo, Sheng-Zheng, Xu, Zi-Xin, Zhou, Cui, Li, Zheng-Hong, Zhou, Xiao-Yan, Xu, Ming-Yi
Publicado 2021

Correction to: Linc-SCRG1 accelerates progression of hepatocellular carcinoma as a ceRNA of miR26a to derepress SKP2

por Hu, Jun-Jie, Zhou, Cui, Luo, Xin, Luo, Sheng-Zheng, Li, Zheng-Hong, Xu, Zi-Xin, Xu, Ming-Yi
Publicado 2021

Serum dihydroxyacetone kinase peptide m/z 520.3 as predictor of disease severity in patients with compensated chronic hepatitis B

por Xu, Ming-Yi, Jia, Xiao-Fang, Qu, Ying, Zheng, Rui-Dan, Yuan, Zheng-Hong, Weng, Hong-Lei, Dooley, Steven, Wang, Xing-Peng, Zhang, Li-Jun, Lu, Lun-Gen
Publicado 2013

Prediction of hepatic necroinflammatory activity in patients with chronic hepatitis B by a simple noninvasive model

por Shen, Fei-Fei, Wang, Yan, Wang, Yi-Fei, Zheng, Rui-Dan, Xian, Jian-Chun, Shi, Jun-Ping, Qu, Ying, Dong, Yu-Wei, Xu, Ming-Yi, Lu, Lun-Gen
Publicado 2018

Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatt...

por Qu, Ying, Song, Yan-Yan, Chen, Cheng-Wei, Fu, Qing-Chun, Shi, Jun-Ping, Xu, Yun, Xie, Qing, Yang, Yong-Feng, Zhou, Yong-Jian, Li, Liang-Ping, Xu, Ming-Yi, Cai, Xiao-Bo, Zhang, Qi-Di, Yu, Hao, Fan, Jian-Gao, Lu, Lun-Gen
Publicado 2021